Results 151 to 160 of about 49,324 (252)

OC 24.1 Effect of the Type of F9 Mutation on the Pharmacokinetic Profile of Patients with Hemophilia B Treated with Extended Half-Life FIX Concentrates

, 2023
Davide Matino, Pierre Chelle, Shannon Jackson, Jerome Teitel, Giancarlo Castaman, Arun Keepanasseril, Emma Iserman, David Lillicrap, Anthony K.C. Chan, Alfonso Iorio   +9 more
openalex   +1 more source

Characteristics of FXa-storing platelets in hemophilia B mice and the influence of alcohol on the platelets [PDF]

, 2023
Wenwen Han, Rui Huang, Binbin Li, Lu Liu, Wenjue Xu, Guowei Zhang   +5 more
openalex   +1 more source

Safety and effectiveness of albutrepenonacog alfa in Japanese patients with hemophilia B: Interim report of a post-marketing surveillance study

, 2022
Teruhisa Fujii, Keiji Nogami, Midori Shima, Hiromi TERAYAMA, Fumihiko SHIMIZU, Masashi Taki   +5 more
openalex   +2 more sources

Direct detection of hemophilia B F9 gene mutation using multiplex PCR and conformation sensitive gel electrophoresis

, 2010
Ki Young Yoo, Hee‐Jin Kim, Kwang Chul Lee   +2 more
openalex   +1 more source

Therapeutic efficacy in a hemophilia B model using a biosynthetic mRNA liver depot system [PDF]

, 2016
Frank DeRosa, Braydon C. Guild, Shrirang Karve, L Smith, Kevin T. Love, J. Robert Dorkin, Kevin Kauffman, J Zhang, Barak Yahalom, Daniel G. Anderson, Michael W. Heartlein   +10 more
openalex   +1 more source

Evaluation of kidney function and damage in patients with hemophilia B-insights from the B-Natural study. [PDF]

Res Pract Thromb Haemost
Astermark J, LeBeau P, Christensson A, Lethagen S, Berntorp E, Shapiro AD, B-Natural Study investigators.   +6 more
europepmc   +1 more source

New developments in the management of moderate-to-severe hemophilia B

, 2016
John P. Sheehan, Moniba Nazeef
openalex   +2 more sources

625. Nonviral Gene Transfer of a Plasmid Encoding a B Domain Variant FVIII/N6 cDNA Reduced Inhibitory Anti-FVIII Antibody Titer in Hemophilia A Mice [PDF]

, 2009

openalex   +1 more source

PB0693 Efficacy and Safety of Eptacog Beta (Recombinant Activated FVII) in Patients with Hemophilia A or B with Inhibitors According to Time to Initial Infusion: A Post-Hoc Analysis from PERSEPT-1

, 2023
Cédric Hermans, Miguel A. Escobar, Yasmina L. Abajas, Sourya Acharya, María Román, Glaivy Batsuli, Yesim Dargaud, Maissaa Janbain, Philip Kuriakose, Johnny Mahlangu, Maria Elisa Mancuso, Wolfgang Miesbach, Shuofeng Yuan, Ian S. Mitchell, Manuel Carção   +14 more
openalex   +1 more source

Treatment patterns and bleeding outcomes in persons with severe hemophilia A and B in a real-world setting [PDF]

, 2020
Cihan Ay, Leonard Perschy, Judit Rejtő, Alexandra Kaider, Ingrid Pabinger   +4 more
openalex   +1 more source